B., V. (2022). A REVIEW ON THE DEVELOPMENT OF FAVIPRAVIR AGAINST SARS COV 2 INFECTION. International Journal of Current Pharmaceutical Research, 14(2), 11–14. https://doi.org/10.22159/ijcpr.2022v14i2.1957